Figure 7From: Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoterIn vivo assess apoptosis by TUNEL assay: Tissue section of meningioma (A, C) and glioma (B, D) at 53 days after treatment. (A) meningioma and (B) glioma treated with Ad/CMV-GFP. (C) meningioma and (D) glioma treated with Ad/gTRAIL. TUNEL staining was performed as described in the Methods.Back to article page